Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV
Clinical trial NCT01701401 · COMPLETED
Trial details
- NCT number
- NCT01701401
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2014-03-01
- Enrollment
- 870
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.